RTF-RTU Vials Market
This report contains market size and forecasts of RTF-RTU Vials in global, including the followin ... Read More
This report contains market size and forecasts of Insulin Dosing Device in global, including the following market information:
Global Insulin Dosing Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Insulin Dosing Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Insulin Dosing Device companies in 2021 (%)
The global Insulin Dosing Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Insulin Dosing Device include Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Copernicus, Dance Biopharm and Debiotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insulin Dosing Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insulin Dosing Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Dosing Device Market Segment Percentages, by Type, 2021 (%)
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Global Insulin Dosing Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Dosing Device Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Care
Others
Global Insulin Dosing Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Insulin Dosing Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insulin Dosing Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Insulin Dosing Device revenues share in global market, 2021 (%)
Key companies Insulin Dosing Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Insulin Dosing Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Copernicus
Dance Biopharm
Debiotech
Insulet
MannKind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
This report contains market size and forecasts of RTF-RTU Vials in global, including the followin ... Read More
This report contains market size and forecasts of Micromobility Telematics System in Global, incl ... Read More
This report contains market size and forecasts of Medical Cartridges in global, including the fol ... Read More
This report contains market size and forecasts of Anxiety and Depression Treatment in Global, inc ... Read More